On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
All content for Brains Behind AI is the property of Ari Yacobi and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
Stats Perform: Patrick Lucey on harnessing true power of sports data through AI
Brains Behind AI
27 minutes
4 years ago
Stats Perform: Patrick Lucey on harnessing true power of sports data through AI
On our 32nd Episode of “Brains Behind AI”, Ari had the opportunity to speak with Patrick Lucey, the Chief Scientist at Stats Perform. Stats Perform is an award-winning Artificial Intelligence team that maximizes the value of global sports coverage dating back over 40 years by coupling it with machine learning technology to generate insights. As an athlete originally from Australia with a deep love for sports, Patrick worked for Disney Research, where he researched automatic sports broadcastin...
Brains Behind AI
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
